Abramson Cancer Center

Abramson Cancer Center
Name	Abramson Cancer Center
Established	1973
Type	Academic medical center
Affiliation	University of Pennsylvania Health System
City	Philadelphia
State	Pennsylvania
Country	United States

Abramson Cancer Center is a leading comprehensive cancer center located in Philadelphia, Pennsylvania, and part of the University of Pennsylvania Health System. It is designated by the National Cancer Institute as a Comprehensive Cancer Center, a recognition of its excellence in laboratory research, clinical care, and community outreach. The center is named in honor of philanthropists Leonard and Madlyn Abramson, whose transformative gift in 1997 enabled its expansion and enhanced its mission to advance cancer care.

Overview

The center integrates the cancer research and clinical care activities of the University of Pennsylvania's Perelman School of Medicine and the University of Pennsylvania Health System. It brings together over 400 faculty members from diverse disciplines, including oncology, radiology, pathology, and surgery, to foster a collaborative environment for discovery and patient care. As a core component of the Penn Medicine network, it provides a full spectrum of services from prevention and screening to cutting-edge treatment and survivorship programs. Its work is supported by substantial funding from organizations like the National Institutes of Health and private foundations.

History

The origins trace back to 1973 with the establishment of the University of Pennsylvania Cancer Center, which consolidated oncology efforts across the university. A pivotal moment occurred in 1997 with a landmark gift from Leonard and Madlyn Abramson, leading to its renaming and the construction of new, dedicated facilities. Under the leadership of directors like John H. Glick and later Chi Van Dang, the center significantly expanded its research portfolio and clinical trials program. It achieved its NCI Comprehensive Cancer Center designation in 1973, a status it has maintained continuously, reflecting a longstanding commitment to the highest standards in cancer science and medicine.

Research_and_Treatment

Research is organized around multidisciplinary programs focusing on major disease areas such as breast cancer, leukemia, pancreatic cancer, and melanoma, as well as cross-cutting themes like immunology, genetics, and cancer biology. The center is renowned for pioneering work in immunotherapy, including the development of CAR T-cell therapy for cancers like acute lymphoblastic leukemia through collaborations with scientists like Carl June. Its clinical enterprise offers advanced treatments including proton therapy, precision medicine guided by genomic profiling, and a vast portfolio of clinical trials managed through entities like the Oncology Clinical Research Unit. The Basser Center for BRCA, established in 2012, is a global leader in research on BRCA1 and BRCA2 mutations.

Facilities_and_Locations

The primary outpatient facility is the Perelman Center for Advanced Medicine, a state-of-the-art building on the campus of the Hospital of the University of Pennsylvania in West Philadelphia. Inpatient cancer care is delivered at the Hospital of the University of Pennsylvania and the Pennsylvania Hospital, one of the nation's oldest hospitals founded by Benjamin Franklin. The center also operates the Roberts Proton Therapy Center, one of the largest and most advanced facilities of its kind. Satellite locations extend its reach throughout the Philadelphia region and New Jersey, including the Penn Medicine Radnor and Penn Medicine Cherry Hill sites.

Affiliations_and_Accreditation

It holds the prestigious Comprehensive Cancer Center designation from the National Cancer Institute. The center is a founding member of the National Comprehensive Cancer Network (NCCN), which develops widely used clinical practice guidelines. Its nursing program has consistently received Magnet recognition from the American Nurses Credentialing Center. It maintains strong affiliations with the Children's Hospital of Philadelphia for pediatric oncology and is a core participant in national research consortia such as the ECOG-ACRIN Cancer Research Group.

Notable_Cases_and_Research_Breakthroughs

A landmark achievement was the first successful use of CAR T-cell therapy in a child with relapsed acute lymphoblastic leukemia in 2012, a treatment pioneered by Carl June and his team. The center's researchers, including Bert Vogelstein, have made seminal contributions to understanding the genetic basis of cancers like colorectal cancer. The Basser Center for BRCA has driven global research into hereditary cancers, influencing prevention strategies worldwide. Its clinicians and scientists continue to lead pivotal trials in novel areas such as cancer vaccines and targeted therapy.

Category:Cancer centers in the United States Category:University of Pennsylvania Category:Medical and health organizations based in Philadelphia Category:Buildings and structures in Philadelphia